SCHEMBL4921477

SCHEMBL4921477

CCCN1Cc2nc3c(-c4ccc(Cl)nc4Cl)cccc3c(N)c2C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.36
▸ PARP1 P09874 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ PARP2 Q9UGN5 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.32
▸ MAPK10 P53779 1/20 0.32
▸ GAA P10253 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ PDE5A O76074 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ ACHE P22303 1/20 0.30
▸ USP2 O75604 1/20 0.30
▸ ATM Q13315 1/20 0.30
▸ KEAP1 Q14145 1/20 0.30
▸ NFE2L2 Q16236 1/20 0.30
▸ CYP1B1 Q16678 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655502 0.91 HTT (0.35) LMNAPARP1HTTPARP2ALDH1A1
SCHEMBL2660762 0.91 HTT (0.35) LMNAPARP1HTTPARP2ALDH1A1
SCHEMBL2660012 0.87 LMNA (0.38) LMNAPARP1HTTPARP2ALDH1A1
SCHEMBL2660780 0.84 GABRG2 (0.42) LMNAPARP1HTTPARP2ALDH1A1
SCHEMBL2660719 0.83 CRHR1 (0.36) LMNAPARP1HTTPARP2ALDH1A1
SCHEMBL4915502 0.83 LMNA (0.36) LMNAPARP1HTTPARP2ALDH1A1
SCHEMBL2660837 0.83 GABRG2 (0.34) LMNAPARP1HTTPARP2ALDH1A1
SCHEMBL2655382 0.83 LMNA (0.38) LMNAPARP1HTTPARP2ALDH1A1
SCHEMBL2660713 0.83 HRH4 (0.42) LMNAPARP1HTTPARP2ALDH1A1
SCHEMBL4921028 0.82 LMNA (0.36) LMNAPARP1HTTPARP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US claimed
US-20080318943-A1 Compounds and Uses Thereof - 848 ASTRAZENECA AB (SE) 2008-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318943-A1 Compounds and Uses Thereof - 848 COMT, BACE1, BDNF LMNA 1909/4885PARP1 1350/4885HTT 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback